Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Newly Diagnosed Diffuse Large B-Cell Lymphoma”

97 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 97 results

Testing effectiveness (Phase 2)Not Yet RecruitingNCT06890585
What this trial is testing

Zanubrutinib, Chidamide, and Rituximab Induction With or Without CHOP Versus R-CHOP in Newly Diagnosed Double-Expressor DLBCL

Who this might be right for
BTK InhibitorsHistone Deacetylase InhibitorDouble Express Diffuse Large B-cell Lymphoma
Li Zhiming 128
Testing effectiveness (Phase 2)Study completedNCT00057811
What this trial is testing

Rituximab, Rasburicase, and Combination Chemotherapy in Treating Young Patients With Newly Diagnosed Advanced B-Cell Leukemia or Lymphoma

Who this might be right for
Childhood Burkitt LymphomaChildhood Diffuse Large Cell LymphomaChildhood Immunoblastic Large Cell Lymphoma+9 more
Children's Oncology Group 97
Not applicableLooking for participantsNCT07072208
What this trial is testing

Pomalidomide, Rituximab and Orelabrutinib Combined With Polatuzumab Vedotin in the Treatment of Newly Diagnosed Elderly Patients With DLBCL

Who this might be right for
Diffuse Large B-Cell Lymphoma
The First Affiliated Hospital of Soochow University 43
Large-scale testing (Phase 3)Ended earlyNCT01659099
What this trial is testing

GA In NEwly Diagnosed Diffuse Large B Cell Lymphoma

Who this might be right for
Diffuse Large B Cell Lymphoma CD20 Positive
The Lymphoma Academic Research Organisation 671
Testing effectiveness (Phase 2)Active Not RecruitingNCT01856192
What this trial is testing

Rituximab and Combination Chemotherapy With or Without Lenalidomide in Treating Patients With Newly Diagnosed Stage II-IV Diffuse Large B Cell Lymphoma

Who this might be right for
Ann Arbor Stage II Diffuse Large B-Cell LymphomaAnn Arbor Stage III Diffuse Large B-Cell LymphomaAnn Arbor Stage IV Diffuse Large B-Cell Lymphoma
National Cancer Institute (NCI) 349
Testing effectiveness (Phase 2)WithdrawnNCT01854372
What this trial is testing

Rituximab-HyperCVAD (R-HCVAD) Alternating With Rituximab-Methotrexate-Cytarabine- (R-MC) in Newly Diagnosed Patients With Diffuse Large B-Cell Lymphoma With MYC-Rearrangement.

Who this might be right for
Newly Diagnosed Diffuse Large B-Cell LymphomaIntermediate (Burkitt-Like) Lymphoma
The University of Texas Health Science Center at San Antonio
Not applicableLooking for participantsNCT05040555
What this trial is testing

R-CDOP Regimen in the Treatment of Newly Diagnosed Non-Hodgkin's Lymphoma With High Tumor Burden

Who this might be right for
Diffuse Large B Cell LymphomaFollicular Lymphoma Grade 3B
oubai, MD/PhD 64
Testing effectiveness (Phase 2)UnknownNCT05290337
What this trial is testing

ZR-CHOP in DLBCL With Specific Gene Abnormality

Who this might be right for
Diffuse Large B Cell Lymphoma
Fudan University 62
Not applicableStudy completedNCT00577798
What this trial is testing

Cardiac Magnetic Resonance Imaging in Patients With Non-Hodgkin Lymphoma or Hodgkin Lymphoma Receiving Doxorubicin

Who this might be right for
Cardiac ToxicityChemotherapeutic Agent ToxicityLymphoma
University of Nebraska 10
Testing effectiveness (Phase 2)UnknownNCT05200312
What this trial is testing

A Phase II Study of Zanubrutinib, Lenalidomide Plus R-CHOP as the First-line Treatment for Diffused Large B-cell Lymphoma

Who this might be right for
Non Hodgkin LymphomaDiffuse Large B Cell Lymphoma
The First Affiliated Hospital with Nanjing Medical University 36
Testing effectiveness (Phase 2)Looking for participantsNCT07371923
What this trial is testing

Application of Zanubrutinib-based Combination Regimens in the Treatment of Newly-diagnosed Diffuse Large B-cell Lymphoma

Who this might be right for
Diffuse Large B Cell Lymphoma (DLBCL)
Beijing Tongren Hospital 50
Early research (Phase 1)Study completedNCT01334502
What this trial is testing

Everolimus, Rituximab, and Combination Chemotherapy in Treating Patients With Newly Diagnosed Untreated Diffuse Large B-Cell Lymphoma

Who this might be right for
Lymphoma
Alliance for Clinical Trials in Oncology 26
Not applicableLooking for participantsNCT06693830
What this trial is testing

CtDNA-guided Therapy Optimization in Newly Diagnosed DLBCL

Who this might be right for
LymphomaLymphoma, B-CellDiffuse Large B Cell Lymphoma+2 more
Hua-Jay J Cherng, MD 40
Very early researchEnded earlyNCT00736450
What this trial is testing

Oblimersen Sodium & Combination Chemotherapy in Treating Patients With Newly Diagnosed Diffuse Large B-Cell Lymphoma

Who this might be right for
Contiguous Stage II Adult Diffuse Large Cell LymphomaNoncontiguous Stage II Adult Diffuse Large Cell LymphomaStage I Adult Diffuse Large Cell Lymphoma+2 more
University of Nebraska 37
Testing effectiveness (Phase 2)Active Not RecruitingNCT04446962
What this trial is testing

LOC-R01 Study of Lenalidomide and Ibrutinib in Association With Rituximab-Methotrexate Procarbazine Vincristin (R-MPV)

Who this might be right for
Lymphoma, Large B-Cell, DiffuseCentral Nervous System Neoplasms, Primary
Institut Curie 118
Large-scale testing (Phase 3)UnknownNCT04789434
What this trial is testing

PD-1 Inhibitor Tislelizumab Maintenance Therapy in Newly Diagnosed DLBCL Patients After ASCT

Who this might be right for
Lymphoma, Large B-Cell, DiffuseTransplantationChemotherapy
Ruijin Hospital 94
Not applicableActive Not RecruitingNCT01787409
What this trial is testing

Cholecalciferol in Improving Survival in Patients With Newly Diagnosed Cancer With Vitamin D Insufficiency

Who this might be right for
Aggressive Non-Hodgkin LymphomaAnaplastic Large Cell LymphomaAngioimmunoblastic T-Cell Lymphoma+12 more
Mayo Clinic 565
Testing effectiveness (Phase 2)UnknownNCT00363090
What this trial is testing

Alemtuzumab and Combination Chemotherapy in Treating Patients With Newly Diagnosed Stage II, Stage III, or Stage IV T-Cell Non-Hodgkin's Lymphoma

Who this might be right for
Lymphoma
Toronto Sunnybrook Regional Cancer Centre 84
Large-scale testing (Phase 3)Study completedNCT00004112
What this trial is testing

Combination Chemotherapy With or Without Rituximab in Treating Patients With Newly Diagnosed Non-Hodgkin's Lymphoma

Who this might be right for
Lymphoma
University of Nebraska
Testing effectiveness (Phase 2)Study completedNCT03465527
What this trial is testing

Pre-phase Treatment Before R-CHOP Chemotherapy in Elderly Patients With Newly Diagnosed DLBCL

Who this might be right for
Diffuse Large B Cell Lymphoma
Kosin University Gospel Hospital 37
Load More Results